- Filed
- Mar 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Feb 27, 2026 | 47.77M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 67.81M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 48.16M sh |
| Capex | FY 2025 · Dec 31, 2025 | $186K |
| Capex | FY 2025 · Dec 31, 2024 | $0 |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$54.36M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$15.56M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $35.69M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $87.23M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $160.48M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $211.88M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $107.6M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $6.98M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $4.93M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $7.27M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $5.31M |
| Current Assets | FY 2025 · Dec 31, 2025 | $105.85M |
| Current Assets | FY 2025 · Dec 31, 2024 | $154.87M |
| Total Assets | FY 2025 · Dec 31, 2025 | $167.74M |
| Total Assets | FY 2025 · Dec 31, 2024 | $217.19M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.88 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$1.53 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.88 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$1.53 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $21.17M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $16.03M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $46.71M |
| Rd Expense restated | FY 2025 · Dec 31, 2024 | $14.34M |
| Net Income | FY 2025 · Dec 31, 2025 | −$59.85M |
| Net Income | FY 2025 · Dec 31, 2024 | −$73.9M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$67.88M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$82.02M |